Scribd
Upload
78 views2 pages

Cipla Company Overview and Market Reach

Cipla is one of the largest generic pharmaceutical companies in the world, founded in India in 1935. It has a presence in over 170 countries and 34 manufacturing facilities in India. Cipla produces affordable drugs to treat diseases like HIV, cardiovascular issues, arthritis, diabetes and depression. The company's vision is to make India self-reliant in healthcare.

Uploaded by

Cherin Sam
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
78 views2 pages

Cipla Company Overview and Market Reach

Cipla is one of the largest generic pharmaceutical companies in the world, founded in India in 1935. It has a presence in over 170 countries and 34 manufacturing facilities in India. Cipla produces affordable drugs to treat diseases like HIV, cardiovascular issues, arthritis, diabetes and depression. The company's vision is to make India self-reliant in healthcare.

Uploaded by

Cherin Sam
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd

CIPLA

 One of the world’s largest generic pharmaceutical companies.


 Founded in 1935
 Founder Khawaja Abdul Hamied
 Headquarters Mumbai, India
 Pharmaceuticals Industry
 Product- Fractional cost drugs to treat HIV +ve patients,
cardiovascular disease, arthritis, diabetes, weight control,
depression and many other health problems.
 Cipla Has a strong market presence in more than 170+ Countries.
 They have 34+ modern manufacturing facilities in India.
 Vision- “To make India self-reliant in healthcare”.

Employees 20,000+
Sales Force 8,000+
Products 2000+ Approvals
Countries 170+ US FDA, WHO-Geneva, MHRA-UK,
Therapeutic TGA-Australia, SUKL-Slovak
15+
Categories Republic, APVMA-Australia, MCC-
Dosage Forms 60+ South Africa, PIC-Germany, Danish
Manufacturing Medical Agency, ANVISA-Brazil,
34+ INVIMA- Colombia, NDA-Uganda,
Facilities
Distributors in India 6,500+ Department of Health-Canada and
Patents 100+ MOH-Saudi Arabia, etc.
World Firsts 30+
Market Share (India) ~5%
As of 31 March, 2015; source: Company website (http://www.cipla.com/)
 
 

You might also like